Laser-assisted cataract surgery – visual outcomes

In recent years femtosecond lasers have been used in a small number of centers to assist in cataract surgery, with theoretical benefits including more precise creation of corneal incisions and the anterior capsulotomy. However the majority of surgeons have failed to see this translate into any meaningful visual benefit for the patient, and indeed the… Read More

Epimacular brachytherapy (X-rays) for wet macular degeneration

This novel treatment was designed for wet macular degeneration, and involves vitrectomy surgery combined with a device which shines radiation on the macula, in order to try to reduce the frequency of injections required. However after 12 months of treatment, it was not found to be effective, and in fact visual outcomes were worse when… Read More

Avastin (bevacizumab) for wet AMD does not increase risk of stroke or heart attack

One of the largest studies to date to examine the relationship between single or multiple intravitreal injections of Avastin (bevacizumab) for wet macular degeneration, studying several thousand patients from British Columbia in Canada, has not found any increased risk of myocardial infarction (heart attack) or stroke in patients receiving the injections: This is obviously… Read More

Routine use of non-steroidal drops after cataract surgery

There are two types of eye drop that can be used to control eye inflammation following cataract surgery – steroid drops, and non-steroidal drops (the latter of which are the eye drop equivalent of something like ibuprofen). Of the two classes, steroid drops are more effective (potent) and almost all surgeons routinely prescribe them following… Read More

Laser-assisted cataract surgery: risk of cystoid macular oedema

Despite increasing interest in the possibility of using femtosecond lasers to assist with cataract surgery, most surgeons have not chosen to adopt the technology due to concerns about increased complication rates combined with very few real-world advantages. This study compared the incidence of cystoid macular oedema (abnormal swelling of the retina) in patients who had… Read More

Treat-and-Extend injections for wet AMD

There has been increasing interest in the Treat-and-Extend model of dosing of intravitreal injections for wet macular degeneration, which aims to reduce the number of visits for patients while individualising treatment frequency depending on disease activity. This latest randomised clinical trial, although studying small numbers of patients, appears to show that this regimen led to… Read More